enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Rifaximin - Wikipedia

    en.wikipedia.org/wiki/Rifaximin

    Rifaximin, sold under the brand name Xifaxan among others, is a non-absorbable, broad-spectrum antibiotic mainly used to treat travelers' diarrhea.It is based on the rifamycin antibiotics family.

  3. Terbium - Wikipedia

    en.wikipedia.org/wiki/Terbium

    2 TbF 3 + F 22 TbF 4 When TbF 4 and caesium fluoride (CsF) is mixed in a stoichiometric ratio in a fluorine gas atmosphere, caesium pentafluoroterbate ( CsTbF 5 ) is obtained. It is an orthorhombic crystal with space group Cmca and a layered structure composed of [TbF 8 ] 4− and 11-coordinated Cs + . [ 35 ]

  4. Elexacaftor/tezacaftor/ivacaftor - Wikipedia

    en.wikipedia.org/wiki/Elexacaftor/tezacaftor/...

    FDA approval for children aged 6–11 was added in January 2021, after a third clinical trial was completed. [33] In 2023, approval was extended to children 25. [34] The US Food and Drug Administration (FDA) granted the application priority review, in addition to fast track, breakthrough therapy, and orphan drug designations.

  5. Extended-release morphine - Wikipedia

    en.wikipedia.org/wiki/Extended-release_morphine

    MST Continus is a 12-hour release formula, therefore it is given 2 times per day. It is available in the following doses: 5 mg, 10 mg, 15 mg, 30 mg, 60 mg, 100 mg and 200 mg tablets (equating to between 0.416 mg/hour and 16.67 mg/hour).

  6. 2C-B - Wikipedia

    en.wikipedia.org/wiki/2C-B

    2C-B (4-bromo-2,5-dimethoxyphenethylamine), also known as Nexus, is a synthetic psychedelic drug of the 2C family, mainly used as a recreational drug. [2] [1] [4] It was first synthesized by Alexander Shulgin in 1974 for use in psychotherapy.

  7. FDA approves opioid-free pain medication with 'no sign of ...

    www.aol.com/fda-approves-opioid-free-pain...

    February 2, 2025 at 1:30 AM A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients.

  8. Tezacaftor - Wikipedia

    en.wikipedia.org/wiki/Tezacaftor

    Tezacaftor is a medication used for the treatment of cystic fibrosis. [1] [2] It is available in fixed-dose combination medications.[3] [4] [5]The combination of tezacaftor with ivacaftor (brand name Symdeko) was approved for medical use in the United States in February 2018, [6] [1] and in Canada in June 2018. [7]

  9. Pyrazinamide - Wikipedia

    en.wikipedia.org/wiki/Pyrazinamide

    The old dose for pyrazinamide was 40–70 mg/kg daily and the incidence of drug-induced hepatitis has fallen significantly since the recommended dose has been reduced to 12–30 mg/kg daily. In the standard four-drug regimen (isoniazid, rifampicin, pyrazinamide, ethambutol ), pyrazinamide is the most common cause of drug-induced hepatitis. [ 13 ]